ranjan

Artificial technologies promise to speed up the process of Drug discovery and development and make it cost effective. New drugs are approved through human clinical trials - year long rigorous procedures starting in animal trials and gradually moving to patients. They cost billions and take many years to complete. Also, patients in trials are exposed to side effects that cannot be predicted. And, if the trial is successful, it has to go through a regulatory approval - it may or may not receive nod from the Regulatory agency. While looking at all technologies, Artificial Intelligence is the most advanced and multifaceted. The technology helps companies aggregate and synthesize information needed for clinical trials, shortening the Drug Development Process. It also helps to understand the mechanisms of disease, establish Biomarkers, Design or Redesign drugs, generate data, models or novel drug candidates, run preclinical experiments, run clinical trials and even analyse the real world e